Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Recruiting · NCT07094048 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 4 | 2026-07-22 | NCT07094048 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CHU de Quebec-Universite Laval | 54 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Intégré de Cancérologie | Québec | Canada | 1 |
| Santé Québec Chaudière-Appalaches | Lévis | Canada | 1 |